- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.09. | WHO adds first mpox vaccine to prequalification list | ||
| 13.09. | World Sepsis Day 2024 highlights need for better sepsis treatments | ||
| 13.09. | Nxera and Cancer Research UK to present promising cancer drug trial at ESMO | ||
| 12.09. | HRT linked to reduced psychosis relapse risk in menopausal women | ||
| 12.09. | Centessa reports positive phase 1 clinical data for ORX750 | ||
| 11.09. | Scotland first in UK to approve new myeloma treatment | ||
| 11.09. | AI-Powered chest X-Rays detect lung cancer early | ||
| 10.09. | Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease | ||
| 10.09. | APL and CurifyLabs partner to support patients with 3D printing medicine technology | ||
| 09.09. | ChatGPT outperforms trainee doctors in assessing respiratory illness in children | ||
| 06.09. | Eli Lilly's once-weekly insulin shows promise in phase 3 trials | ||
| 05.09. | AMBLor prognostic melanoma biomarker receives UKCA Mark | ||
| 05.09. | European Commission grants orphan drug designation for Vivet's VTX-806 | ||
| 28.08. | Acelyrin's izokibep for hidradenitis suppurativa reveals positive results | ||
| 28.08. | myTomorrows and Pancreatic Cancer Europe partner on clinical trials | ||
| 27.08. | National campaign launches to end prostate cancer postcode lottery | ||
| 27.08. | Improving tracking of AMR bacteria in hospitals using new genomic technique | ||
| 23.08. | MHRA approves Astellas' Vyloy combination for gastric cancer | ||
| 23.08. | Association for Medical Education in Europe AMEE 2024 conference | ||
| 22.08. | New drug trial to investigate treatment for patients with bronchiectasis | ||
| 22.08. | SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK | ||
| 21.08. | AMR testing technology from QuantaMatrix backed by research paper in Nature | ||
| 21.08. | GOSH and Oliver Patch in cancer research partnership with Innovative Trials | ||
| 20.08. | Theramex's Eladynos recommended by NICE for post-menopausal bone disease | ||
| 20.08. | eXmoor pharma's manufacturing facility receives licence from MHRA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
